Obesity and Biochemical Recurrence in Clinically Localized Prostate Cancer: A Systematic Review and Meta-Analysis of 86,490 Patients

The association of obesity with biochemical recurrence (BCR) after treatment of clinically localized prostate cancer shows inconsistent results. Scientists systematically review all evidence evaluating obesity as a prognostic factor for BCR.